SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
8 |
103.0 |
% |
9.0 |
25.46 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107090 |
3073 |
SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
9 |
100.0 |
% |
2.0 |
6.0 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107094 |
3073 |
W/Jpe |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540 days
| 7 |
99.9 |
% |
0.1 |
0.26 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
wistar |
109109 |
3108 |
GK/Jpe |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then alpha-lipoic acid (50 mg/kg) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540 days
| 7 |
99.5 |
% |
0.05 |
0.13 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
|
109113 |
3108 |
SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled GSK2181236A content diet (0.1 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
6 |
98.0 |
% |
5.0 |
12.25 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107091 |
3073 |
GK/Jpe |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540 days
| 7 |
99.6 |
% |
0.01 |
0.03 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
|
109110 |
3108 |
SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
4 |
111.0 |
% |
3.0 |
6.0 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107093 |
3073 |
SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium chloride content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled GSK2181236A content diet (1 mg/kg/d) (for 49 days) |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
9 |
112.0 |
% |
3.0 |
9.0 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107092 |
3073 |
GK/Jpe |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) then soybean oil (2 ml/kg) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540 days
| 7 |
99.5 |
% |
0.11 |
0.29 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
|
109112 |
3108 |
SHRSP/A3NCrl |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012. |
vasodilation trait |
male |
141 days-148 days |
14 |
108.0 |
% |
4.0 |
14.97 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
percent reversal of contractile response to 0.3uM phenylephrine |
107089 |
3073 |
GK/Jpe |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled cholesterol content diet (1.25 %) (for 90 days) and controlled cocoa butter content diet (7.5 %) (for 90 days) |
Sena CM, etal., Br J Pharmacol. 2008 Mar;153(5):894-906. doi: 10.1038/sj.bjp.0707474. Epub 2007 Oct 1. |
vasodilation trait |
male |
540 days
| 7 |
99.5 |
% |
0.15 |
0.4 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
|
109111 |
3108 |